Leaders at City of Hope forecast that in 2024 more people will benefit from cancer breakthroughs, including research that unlocks the biology behind cancer disparities, wider access to CAR T cell therapy and rapid whole genome sequencing.
The Latin American country with the highest age-standardized cancer mortality rate in 2022 was Uruguay, with 128.3 deaths per 100,000 population. Jamaica and Barbados followed, with cancer mortality rates of 116.6 and 113.3, respectively. As of that year, breast cancer was the cancer type with ...
Could breast cancer survival rates be improved simply by timing treatment to a specific stage of the menstrual cycle? Mouse and human data suggest sensitivity to chemotherapy is affected by fluctuations in ovarian hormones. Wendy V. Ingman
The data also point to racial disparities in early detection; in addition, overall cancer death rates are 19% higher in Black men than in White men, largely due to the number of deaths from prostate cancer. Hispanic patients have one of the highest rates of HPV-associated cervical cancer; ...
The purpose of this study was to project mortality rates in the United Kingdom for the period 2006–2025 for 21 major cancers on the basis of the observed trends in mortality rates during 1971–2005, and to estimate the implication in terms of expected d
Hasbani noted that the rate of cancer patients in Lebanon is similar to or higher than rates in Europe. The most common reasons of cancers in Lebanon, according to Hasbani, are air pollution, waste burning and contamination of groundwater and irrigation water. ...
have been associated with an increased risk of ovarian cancer. The global rise in obesity rates over the past few decades may have contributed to the growing prevalence of epithelial ovarian cancer. Besides, certain genetic mutations, such as BRCA1 and BRCA2 mutations, are known to increase the...
From 2000 to 2020, U.S. age-adjusted cancer mortality rates decreased significantly, but racial and ethnic disparities persisted for certain cancers, according to a research letter published online Jan. 12 inJAMA Health Forum. Ad Anjali Gupta and Tomi Akinyemiju, Ph.D., from the Duke Universit...
In this non-comparative trial, patients withBRAFV600-mutant resectable melanoma received either pembrolizumab alone, a sequential combination of pembrolizumab, dabrafenib and trametinib, or a concurrent combination thereof, showing encouraging clinical response rates in the concurrent therapy arm and awaiting...
04 October 2024|Open Access Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk Lung cancer is the leading cause of cancer mortality, despite declining smoking rates. Gorman et al. report multi-ancestry GWAS meta-analyses of lung...